302 related articles for article (PubMed ID: 25283719)
1. Autoantibodies to neurofascin-186 and gliomedin in multifocal motor neuropathy.
Notturno F; Di Febo T; Yuki N; Fernandez Rodriguez BM; Corti D; Nobile-Orazio E; Carpo M; De Lauretis A; Uncini A
J Neuroimmunol; 2014 Nov; 276(1-2):207-12. PubMed ID: 25283719
[TBL] [Abstract][Full Text] [Related]
2. Contactin-1 and Neurofascin-155/-186 Are Not Targets of Auto-Antibodies in Multifocal Motor Neuropathy.
Doppler K; Appeltshauser L; Krämer HH; Ng JK; Meinl E; Villmann C; Brophy P; Dib-Hajj SD; Waxman SG; Weishaupt A; Sommer C
PLoS One; 2015; 10(7):e0134274. PubMed ID: 26218529
[TBL] [Abstract][Full Text] [Related]
3. Autoantibody responses to nodal and paranodal antigens in chronic inflammatory neuropathies.
Mathey EK; Garg N; Park SB; Nguyen T; Baker S; Yuki N; Yiannikas C; Lin CS; Spies JM; Ghaoui R; Barnett MH; Vucic S; Pollard JD; Kiernan MC
J Neuroimmunol; 2017 Aug; 309():41-46. PubMed ID: 28601286
[TBL] [Abstract][Full Text] [Related]
4. Nodal proteins are target antigens in Guillain-Barré syndrome.
Devaux JJ; Odaka M; Yuki N
J Peripher Nerv Syst; 2012 Mar; 17(1):62-71. PubMed ID: 22462667
[TBL] [Abstract][Full Text] [Related]
5. Multifocal motor neuropathy. Serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates.
Pestronk A; Choksi R
Neurology; 1997 Nov; 49(5):1289-92. PubMed ID: 9371910
[TBL] [Abstract][Full Text] [Related]
6. Neurofascin antibodies in autoimmune, genetic, and idiopathic neuropathies.
Burnor E; Yang L; Zhou H; Patterson KR; Quinn C; Reilly MM; Rossor AM; Scherer SS; Lancaster E
Neurology; 2018 Jan; 90(1):e31-e38. PubMed ID: 29187518
[TBL] [Abstract][Full Text] [Related]
7. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
[TBL] [Abstract][Full Text] [Related]
8. [Antiganglioside antibodies: when, which and for what].
Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
[TBL] [Abstract][Full Text] [Related]
9. Acute-onset multifocal motor neuropathy (AMMN): how we meet the diagnosis.
Galassi G; Girolami F
Int J Neurosci; 2012 Aug; 122(8):413-22. PubMed ID: 22463688
[TBL] [Abstract][Full Text] [Related]
10. [Antibodies to GM1 ganglioside in motor neuron disease--in comparison with demyelinating neuropathy].
Irie S; Saito T; Ogino M; Ito H; Kowa H
Rinsho Shinkeigaku; 1992 Oct; 32(10):1075-80. PubMed ID: 1297550
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy.
Delmont E; Manso C; Querol L; Cortese A; Berardinelli A; Lozza A; Belghazi M; Malissart P; Labauge P; Taieb G; Yuki N; Illa I; Attarian S; Devaux JJ
Brain; 2017 Jul; 140(7):1851-1858. PubMed ID: 28575198
[TBL] [Abstract][Full Text] [Related]
12. Anti-ganglioside complex IgM antibodies in multifocal motor neuropathy and chronic immune-mediated neuropathies.
Nobile-Orazio E; Giannotta C; Briani C
J Neuroimmunol; 2010 Feb; 219(1-2):119-22. PubMed ID: 20006388
[TBL] [Abstract][Full Text] [Related]
13. [A case of chronic inflammatory demyelinating polyneuropathy with recurrent ophthalmoplegia, persistent conduction block, antibody activity against gangliosides GM1].
Ryo M; Saito T; Kunii N; Hasegawa H; Kowa H
Rinsho Shinkeigaku; 1994 Jul; 34(7):702-6. PubMed ID: 7955728
[TBL] [Abstract][Full Text] [Related]
14. Neurofascin as a target for autoantibodies in peripheral neuropathies.
Ng JK; Malotka J; Kawakami N; Derfuss T; Khademi M; Olsson T; Linington C; Odaka M; Tackenberg B; Prüss H; Schwab JM; Harms L; Harms H; Sommer C; Rasband MN; Eshed-Eisenbach Y; Peles E; Hohlfeld R; Yuki N; Dornmair K; Meinl E
Neurology; 2012 Dec; 79(23):2241-8. PubMed ID: 23100406
[TBL] [Abstract][Full Text] [Related]
15. Cytokine profiles in multifocal motor neuropathy and progressive muscular atrophy.
Vlam L; Stam M; de Jager W; Cats EA; van den Berg LH; van der Pol WL
J Neuroimmunol; 2015 Sep; 286():1-4. PubMed ID: 26298317
[TBL] [Abstract][Full Text] [Related]
16. IVIG blocks complement deposition mediated by anti-GM1 antibodies in multifocal motor neuropathy.
Yuki N; Watanabe H; Nakajima T; Späth PJ
J Neurol Neurosurg Psychiatry; 2011 Jan; 82(1):87-91. PubMed ID: 20667861
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to neurofascin exacerbate adoptive transfer experimental autoimmune neuritis.
Yan W; Nguyen T; Yuki N; Ji Q; Yiannikas C; Pollard JD; Mathey EK
J Neuroimmunol; 2014 Dec; 277(1-2):13-7. PubMed ID: 25262157
[TBL] [Abstract][Full Text] [Related]
18. [Clinical utility of measurement for anti-GM1 and anti-GQ1b antibodies].
Tagawa Y; Matsumoto Y; Yuki N
No To Shinkei; 1998 Sep; 50(9):849-53. PubMed ID: 9789308
[TBL] [Abstract][Full Text] [Related]
19. Multifocal motor neuropathy: serum IgM binding to a GM1 ganglioside-containing lipid mixture but not to GM1 alone.
Pestronk A; Choksi R; Blume G; Lopate G
Neurology; 1997 Apr; 48(4):1104-6. PubMed ID: 9109910
[TBL] [Abstract][Full Text] [Related]
20. Multifocal motor neuropathy human sera block distal motor nerve conduction in mice.
Roberts M; Willison HJ; Vincent A; Newsom-Davis J
Ann Neurol; 1995 Jul; 38(1):111-8. PubMed ID: 7611713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
